US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arrowhead Pharmaceuticals

15.74

-0.4800-2.96%

Post-market: 15.52-0.2231-1.42%19:10 EDT

Volume:1.22M

Turnover:19.22M

Market Cap:2.17B

PE:-13.85

High:16.11

Open:15.62

Low:15.54

Close:16.22

Loading ...

Overview Company News Filings

Arrowhead announces topline results from ARO-C3 trial

Arrowhead Pharmaceuticals Inc - Aro-C3 Generally Well-Tolerated in Patients With Igan

THOMSON REUTERS

Arrowhead Pharmaceuticals Announces Topline Results From Part 2 of Phase 1/2 Study of Aro-C3 in Patients With Iga Nephropathy

THOMSON REUTERS

Arrowhead Pharmaceuticals Inc - No Serious or Severe Treatment Emergent Adverse Events Reported

THOMSON REUTERS

Arrowhead Pharmaceuticals Announces Topline Results from Part 2 of Phase 1/2 Study of ARO-C3 in Patients with IgA Nephropathy

Arrowhead Pharmaceuticals Presents Data on Two Clinical-Stage Candidates for Obesity Treatment

MT Newswires Live

Arrowhead Pharmaceuticals Showcases Two Clinical-Stage RNAi-Based Candidates to Treat Obesity and Metabolic Diseases

Arrowhead Pharmaceuticals Launches on Rare Disease Day New Patient-Centric Resources for Those Affected by Familial Chylomicronemia Syndrome (Fcs)

THOMSON REUTERS

Arrowhead Pharmaceuticals Launches on Rare Disease Day New Patient-Centric Resources for Those Affected by Familial Chylomicronemia Syndrome (FCS)

Arrowhead presents preclinical results on ARO-ALK7

Arrowhead Pharmaceuticals Presents Preclinical Data on ARO-ALK7 for Treatment of Obesity

Arrowhead Pharmaceuticals Price Target Cut to $38.00/Share From $51.00 by B. Riley Securities

B. Riley Adjusts Price Target on Arrowhead Pharmaceuticals to $38 From $51, Keeps Buy Rating

MT Newswires Live

Arrowhead Pharmaceuticals Price Target Maintained With a $80.00/Share by HC Wainwright & Co.

Arrowhead Pharmaceuticals: Promising Pipeline Amidst Cautious Financial Outlook Warrants Hold Rating

Arrowhead Pharmaceuticals: Promising Drug Approval and Expanding Pipeline Justify Buy Rating

Stock Track | Arrowhead Pharmaceuticals Plummets 5.08% Intraday on Widening Q1 Losses and Missed Expectations

ARWR: Multiple Catalysts Ahead in 2025…

Zacks Small Cap Research

Arrowhead Pharmaceuticals First Quarter 2025 Earnings: Misses Expectations

Simply Wall St.

Arrowhead Pharmaceuticals’ Earnings Call Highlights Growth and Challenges

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ARWR/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ARWR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARWR\",,,,,undefined,":{"symbol":"ARWR","market":"US","secType":"STK","nameCN":"Arrowhead Pharmaceuticals","latestPrice":15.74,"timestamp":1749844800000,"preClose":16.22,"halted":0,"volume":1219137,"hourTrading":{"tag":"盘后","latestPrice":15.5169,"preClose":15.74,"latestTime":"19:10 EDT","volume":45673,"amount":718866.4012,"timestamp":1749856251747},"delay":0,"floatShares":119000000,"shares":138100435,"eps":-1.136657,"marketStatus":"Market Closed","change":-0.48,"latestTime":"06-13 16:00:00 EDT","open":15.62,"high":16.105,"low":15.54,"amount":19217001.731367,"amplitude":0.034834,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.136657,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750060800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":740203200000,"exchange":"NASDAQ","adjPreClose":16.22,"preHourTrading":{"tag":"盘前","latestPrice":15.65,"preClose":16.22,"latestTime":"09:29 EDT","volume":4650,"amount":74458.70625,"timestamp":1749821370033},"postHourTrading":{"tag":"盘后","latestPrice":15.5169,"preClose":15.74,"latestTime":"19:10 EDT","volume":45673,"amount":718866.4012,"timestamp":1749856251747},"volumeRatio":0.8686922854208706,"impliedVol":0.5721,"impliedVolPercentile":0.584},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARWR\",,,,,undefined,":{"symbol":"ARWR","floatShares":119000000,"roa":"-5.86%","roe":"-26.22%","lyrEps":-5.004783,"volumeRatio":0.8686922854208706,"shares":138100435,"dividePrice":0,"high":16.105,"amplitude":0.034834,"preClose":16.22,"low":15.54,"week52Low":9.57,"pbRate":"3.18","psRate":"3.99","week52High":30.41,"institutionHeld":0.7485,"latestPrice":15.74,"eps":-1.136657,"divideRate":0,"volume":1219137,"delay":0,"ttmEps":-1.136657,"open":15.62,"prevYearClose":18.8,"prevWeekClose":16.81,"prevMonthClose":16.07,"prevQuarterClose":12.74,"fiveDayClose":16.81,"twentyDayClose":15.34,"sixtyDayClose":15.47},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ARWR\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2518924031","title":"Arrowhead announces topline results from ARO-C3 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2518924031","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518924031?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:35","pubTimestamp":1741606520,"startTime":"0","endTime":"0","summary":"Arrowhead (ARWR) announced topline results from Part 2 of a Phase 1/2 clinical study of ARO-C3, the company’s investigational RNA interference ther...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/arrowhead-announces-topline-results-from-aro-c3-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/arrowhead-announces-topline-results-from-aro-c3-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ARWR","BK4588","BK4505","BK4585","RNA"],"gpt_icon":0},{"id":"2518924715","title":"Arrowhead Pharmaceuticals Inc - Aro-C3 Generally Well-Tolerated in Patients With Igan","url":"https://stock-news.laohu8.com/highlight/detail?id=2518924715","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518924715?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:30","pubTimestamp":1741606213,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PT0MA:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4588","BK4585","ARWR"],"gpt_icon":0},{"id":"2518247169","title":"Arrowhead Pharmaceuticals Announces Topline Results From Part 2 of Phase 1/2 Study of Aro-C3 in Patients With Iga Nephropathy","url":"https://stock-news.laohu8.com/highlight/detail?id=2518247169","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518247169?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:30","pubTimestamp":1741606213,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PT0MA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARWR","BK4585","BK4139","BK4588"],"gpt_icon":0},{"id":"2518247147","title":"Arrowhead Pharmaceuticals Inc - No Serious or Severe Treatment Emergent Adverse Events Reported","url":"https://stock-news.laohu8.com/highlight/detail?id=2518247147","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518247147?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:30","pubTimestamp":1741606213,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PT0MA:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4588","BK4139","ARWR"],"gpt_icon":0},{"id":"2518922845","title":"Arrowhead Pharmaceuticals Announces Topline Results from Part 2 of Phase 1/2 Study of ARO-C3 in Patients with IgA Nephropathy","url":"https://stock-news.laohu8.com/highlight/detail?id=2518922845","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518922845?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:30","pubTimestamp":1741606200,"startTime":"0","endTime":"0","summary":"- ARO-C3 achieved deep and sustained reductions in alternative pathway complement activity and proteinuria. - Mean sustained reductions in C3 of ≥87%, AH50 of ≥76%, Wieslab AP of ≥89% through week 24. - Mean reduction in spot urine protein-to-creatinine ratio  of 41% by week 24. PASADENA, Calif., March 10, 2025----Arrowhead Pharmaceuticals, Inc.  today announced topline results from Part 2 of a Phase 1/2 clinical study of ARO-C3, the company’s investigational RNA interference  therapeutic designed to reduce liver production of complement component 3  as a potential therapy for various complement mediated diseases. The company plans to present additional results at a medical meeting in 2025.Patients with IgA nephropathy   received subcutaneous doses of ARO-C3  on Days 1, 29, and 113 and were followed through Day 169. Maximum mean reduction in C3 of 89% and mean sustained reduction of greater than 87% from baseline through week 24","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/arrowhead-pharmaceuticals-announces-topline-results-113000429.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","BK4585","BK4139","ARWR"],"gpt_icon":0},{"id":"2517031165","title":"Arrowhead Pharmaceuticals Presents Data on Two Clinical-Stage Candidates for Obesity Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2517031165","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517031165?lang=en_us&edition=fundamental","pubTime":"2025-03-06 22:48","pubTimestamp":1741272537,"startTime":"0","endTime":"0","summary":"Arrowhead Pharmaceuticals  said Thursday it has presented preclinical data supporting two RNA-interference-based investigational therapeutics it is developing, with the potential to reduce body weight and fat mass and preserve lean muscle mass compared with currently approved obesity therapies.Data from its ARO-INHBE candidate preclinical results showed a 19% suppression in body weight gain relative to vehicle controls, while data from its ARO-ALK7 candidate preclinical results showed a 39% suppression, the company said.Arrowhead is currently conducting phase 1/2 clinical studies of the two candidates. The company expects initial data from its ARO-INHBE study year-end 2025, and anticipates dosing in the ARO-ALK7 study to begin in the second quarter with initial data from the single-ascending dose portion of the study possible also by year-end 2025.The company presented the data at the RNA Leaders Europe Congress 2025 held March 4-6 in Basel, Switzerland.Price: 16.89, Change: -0.46, Per","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SSI","BK4588","BK4585","BK4139","ARWR"],"gpt_icon":0},{"id":"2517716889","title":"Arrowhead Pharmaceuticals Showcases Two Clinical-Stage RNAi-Based Candidates to Treat Obesity and Metabolic Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2517716889","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517716889?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:45","pubTimestamp":1741268700,"startTime":"0","endTime":"0","summary":"- ARO-INHBE and ARO-ALK7 both target a known pathway that signals the body to store fat in adipose tissue with a novel mechanism of action that may better preserve lean muscle mass compared to currently approved obesity therapies. - Data highlight Arrowhead’s leadership in the use of RNA interference to potentially treat Obesity. DIO mice treated with an ALK7 siRNA exhibit a 39% suppression in body weight gain relative to controls. Adipose ALK7 silencing reduced fat mass by 50% while preserving lean mass. Similar to INHBE silencing in hepatocytes, ALK7 silencing in adipocytes enhanced catecholamine sensitivity, increasing lipid mobilization and oxidation, which was not associated with liver","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/arrowhead-pharmaceuticals-showcases-two-clinical-134500669.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","BK4139","SSI","ARWR","BK4585"],"gpt_icon":0},{"id":"2514229263","title":"Arrowhead Pharmaceuticals Launches on Rare Disease Day New Patient-Centric Resources for Those Affected by Familial Chylomicronemia Syndrome (Fcs)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514229263","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514229263?lang=en_us&edition=fundamental","pubTime":"2025-02-28 22:00","pubTimestamp":1740751201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nTUA42KS62:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4585","BK4139","ARWR"],"gpt_icon":0},{"id":"2514327974","title":"Arrowhead Pharmaceuticals Launches on Rare Disease Day New Patient-Centric Resources for Those Affected by Familial Chylomicronemia Syndrome (FCS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514327974","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514327974?lang=en_us&edition=fundamental","pubTime":"2025-02-28 22:00","pubTimestamp":1740751200,"startTime":"0","endTime":"0","summary":"New Patient Resource Hub: Arrowhead expands its We’ll Get There Soon campaign with the launch of a dedicated patient website, providing education, tools, and support for those living with FCS and extremely high triglycerides. Amplifying Patient Voices: The Spotlight on FCS white paper shares real patient experiences, highlighting the challenges of managing this ultra-rare disease and the need for greater awareness. Commitment to the FCS Community: On Rare Disease Day and beyond, Arrowhead remains dedicated to elevating patient voices and fostering community engagement. #ForFCS. PASADENA, Calif., February 28, 2025----Arrowhead Pharmaceuticals, Inc.  marks Rare Disease Day with the expansion of the We’ll Get There Soon campaign, initially launched for healthcare providers in November 2024. This new phase introduces a dedicated educational website, www.LowerMyTGs.com, and the Spotlight on FCS white paper, which provides essential resources and support for those affected by Familial Chylom","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/arrowhead-pharmaceuticals-launches-rare-disease-140000788.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4090","BK4153","BK4588","BK4585","TG","BK4139","ARWR"],"gpt_icon":0},{"id":"2514099545","title":"Arrowhead presents preclinical results on ARO-ALK7","url":"https://stock-news.laohu8.com/highlight/detail?id=2514099545","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514099545?lang=en_us&edition=fundamental","pubTime":"2025-02-25 21:01","pubTimestamp":1740488474,"startTime":"0","endTime":"0","summary":"Arrowhead (ARWR) announced preclinical results on ARO-ALK7, the company’s investigational RNA interference therapeutic targeting Activin receptor-l...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/arrowhead-presents-preclinical-results-on-aro-alk7?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/arrowhead-presents-preclinical-results-on-aro-alk7?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARWR","BK4588","BK4505","BK4139","RNA","BK4585"],"gpt_icon":0},{"id":"2514095256","title":"Arrowhead Pharmaceuticals Presents Preclinical Data on ARO-ALK7 for Treatment of Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2514095256","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514095256?lang=en_us&edition=fundamental","pubTime":"2025-02-25 20:30","pubTimestamp":1740486600,"startTime":"0","endTime":"0","summary":"PASADENA, Calif., February 25, 2025----Arrowhead Pharmaceuticals, Inc.  today announced preclinical results on ARO-ALK7, the company’s investigational RNA interference  therapeutic targeting Activin receptor-like kinase 7  being developed as a potential treatment for obesity. The results were presented in a poster at the Keystone Symposia on Obesity and Adipose Tissue held February 23–26, 2025 in Banff, AB, Canada.ARO-ALK7 is the first RNAi-based therapy to directly target a gene expressed in adipose tissue and highlights Arrowhead’s leadership in the delivery of siRNA to multiple tissues and cell types throughout the body utilizing its proprietary and differentiated Targeted RNAi Molecule  platform. Arrowhead received regulatory clearance to initiate a Phase 1/2a clinical trial of ARO-ALK7 in New Zealand, which the company anticipates will begin dosing in the second quarter of 2025.Single subcutaneous doses of ARO-ALK7 led to dose-dependent and durable reductions in ALK7 mRNA in abdom","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/arrowhead-pharmaceuticals-presents-preclinical-data-123000962.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","ARWR","BK4139","BK4585"],"gpt_icon":0},{"id":"2511613486","title":"Arrowhead Pharmaceuticals Price Target Cut to $38.00/Share From $51.00 by B. Riley Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2511613486","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511613486?lang=en_us&edition=fundamental","pubTime":"2025-02-15 01:50","pubTimestamp":1739555400,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ARWR/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 14, 2025 12:50 ET (17:50 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARWR","RILY"],"gpt_icon":0},{"id":"2511698681","title":"B. Riley Adjusts Price Target on Arrowhead Pharmaceuticals to $38 From $51, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2511698681","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511698681?lang=en_us&edition=fundamental","pubTime":"2025-02-14 21:33","pubTimestamp":1739540015,"startTime":"0","endTime":"0","summary":"Arrowhead Pharmaceuticals (ARWR) has an average rating of overweight and mean price target of $41.42, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic resear","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ARWR","RILY"],"gpt_icon":0},{"id":"2511517177","title":"Arrowhead Pharmaceuticals Price Target Maintained With a $80.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2511517177","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511517177?lang=en_us&edition=fundamental","pubTime":"2025-02-13 18:11","pubTimestamp":1739441460,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ARWR/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 13, 2025 05:11 ET (10:11 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARWR"],"gpt_icon":0},{"id":"2511629835","title":"Arrowhead Pharmaceuticals: Promising Pipeline Amidst Cautious Financial Outlook Warrants Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2511629835","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511629835?lang=en_us&edition=fundamental","pubTime":"2025-02-13 13:39","pubTimestamp":1739425169,"startTime":"0","endTime":"0","summary":"Analyst Mani Foroohar of Leerink Partners maintained a Hold rating on Arrowhead Pharmaceuticals (ARWR – Research Report), retaining the price targe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/arrowhead-pharmaceuticals-promising-pipeline-amidst-cautious-financial-outlook-warrants-hold-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/arrowhead-pharmaceuticals-promising-pipeline-amidst-cautious-financial-outlook-warrants-hold-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARWR"],"gpt_icon":0},{"id":"2511307910","title":"Arrowhead Pharmaceuticals: Promising Drug Approval and Expanding Pipeline Justify Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2511307910","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511307910?lang=en_us&edition=fundamental","pubTime":"2025-02-13 01:05","pubTimestamp":1739379926,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on Arrowhead Pharmaceuticals (ARWR – Research Report) today and set a price target...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/arrowhead-pharmaceuticals-promising-drug-approval-and-expanding-pipeline-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/arrowhead-pharmaceuticals-promising-drug-approval-and-expanding-pipeline-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARWR"],"gpt_icon":0},{"id":"1120725347","title":"Stock Track | Arrowhead Pharmaceuticals Plummets 5.08% Intraday on Widening Q1 Losses and Missed Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=1120725347","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120725347?lang=en_us&edition=fundamental","pubTime":"2025-02-12 23:02","pubTimestamp":1739372539,"startTime":"0","endTime":"0","summary":"Arrowhead Pharmaceuticals, a biopharmaceutical company focused on developing targeted RNA interference  therapeutics, saw its stock plummet 5.08% in Wednesday's intraday trading session. This significant decline followed the company's disappointing first-quarter 2025 earnings report, which missed analysts' expectations and showcased widening losses.The key financial highlights from the report were:. Net loss of $173.1 million, a 30% increase from the same quarter last year. Earnings per share lo","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Stock Track | Arrowhead Pharmaceuticals Plummets 5.08% Intraday on Widening Q1 Losses and Missed Expectations","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ARWR"],"gpt_icon":0},{"id":"2511958135","title":"ARWR: Multiple Catalysts Ahead in 2025…","url":"https://stock-news.laohu8.com/highlight/detail?id=2511958135","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511958135?lang=en_us&edition=fundamental","pubTime":"2025-02-12 22:22","pubTimestamp":1739370120,"startTime":"0","endTime":"0","summary":"On January 17, 2025, Arrowhead Pharmaceuticals, Inc.  announced that the U.S. Food and Drug Administration  accepted the New Drug Application  for plozasiran for the treatment of familial chylomycronemia syndrome , with a Prescription Drug User Fee Act  action date of November 18, 2025. The agency also indicated that it did not currently plan to hold an advisory committee meeting. We anticipate the company submitting additional applications for approval of plozasiran for the treatment of FCS with other regulatory agencies in 2025.The NDA is based in part on the successful Phase 3 PALISADE trial, the results of which were recently published in The New England Journal of Medicine . The trial met its primary endpoint and showed that treatment with plozasiran led to a median change from baseline of 80% in fasting triglycerides along with a statistically significant 83% reduction in the risk of developing acute pancreatitis compared to placebo.The company has initiated a Phase 1/2a trial of","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/arwr-multiple-catalysts-ahead-2025-142200380.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4135","BK4585","ARWR","BK4588","CNS"],"gpt_icon":0},{"id":"2510327377","title":"Arrowhead Pharmaceuticals First Quarter 2025 Earnings: Misses Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2510327377","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510327377?lang=en_us&edition=fundamental","pubTime":"2025-02-12 18:58","pubTimestamp":1739357899,"startTime":"0","endTime":"0","summary":"NasdaqGS:ARWR Earnings and Revenue Growth February 12th 2025. All figures shown in the chart above are for the trailing 12 month  period. Revenue missed analyst estimates by 87%. Earnings per share  also missed analyst estimates significantly.Looking ahead, revenue is forecast to grow 42% p.a. on average during the next 3 years, compared to a 21% growth forecast for the Biotechs industry in the US.The company's shares are down 4.0% from a week ago.Before you take the next step you should know about the 5 warning signs for Arrowhead Pharmaceuticals that we have uncovered.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/arrowhead-pharmaceuticals-first-quarter-2025-105819431.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ARWR"],"gpt_icon":0},{"id":"2510362599","title":"Arrowhead Pharmaceuticals’ Earnings Call Highlights Growth and Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2510362599","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510362599?lang=en_us&edition=fundamental","pubTime":"2025-02-12 08:03","pubTimestamp":1739318599,"startTime":"0","endTime":"0","summary":"Arrowhead Pharmaceuticals, Inc. (($ARWR)) has held its Q1 earnings call. Read on for the main highlights of the call. Arrowhead Pharmaceuticals’ re...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/arrowhead-pharmaceuticals-earnings-call-highlights-growth-and-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/arrowhead-pharmaceuticals-earnings-call-highlights-growth-and-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARWR"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":99,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARWR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-12","symbol":"ARWR","fiscalQuarterEnding":"2025/03","expectedEps":-0.06,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"post","actualEps":2.75},{"market":"US","date":"2025-02-10","symbol":"ARWR","fiscalQuarterEnding":"2024/12","expectedEps":-0.42,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739163600000,"reportTimeType":"post","actualEps":-1.39},{"market":"US","date":"2024-11-26","symbol":"ARWR","fiscalQuarterEnding":"2024/09","expectedEps":-0.63,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1732597200000,"reportTimeType":"post","actualEps":-1.38},{"market":"US","date":"2024-08-08","symbol":"ARWR","fiscalQuarterEnding":"2024/06","expectedEps":-0.58,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"post","actualEps":-1.38},{"market":"US","date":"2024-05-09","symbol":"ARWR","fiscalQuarterEnding":"2024/03","expectedEps":-0.06,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":-1.02}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARWR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARWR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1333,"buy":0.5333,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5333,"analysts":15,"updateTime":1717646400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ARWR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ARWR","date":"2025-06-13","current":-15.558829,"percent":0.68878,"low":-296.588514,"twenty":-62.792449,"median":-23.478536,"eighty":-6.601655,"high":547.43255,"avg":-26.746963,"sd":100.105026,"marketCap":2239989055},"quantilePoints":[{"date":"2020-06-19","current":392.182515,"twenty":-18.275409,"median":-3.992874,"eighty":60.10843,"marketCap":3738132354},{"date":"2020-06-26","current":462.012999,"twenty":-18.275409,"median":-3.957597,"eighty":60.495173,"marketCap":4403729565},{"date":"2020-07-02","current":471.943021,"twenty":-18.275409,"median":-3.92846,"eighty":61.039647,"marketCap":4498378710},{"date":"2020-07-10","current":475.253029,"twenty":-18.275409,"median":-3.891958,"eighty":61.895529,"marketCap":4529928425},{"date":"2020-07-17","current":523.408301,"twenty":-18.275409,"median":-3.871005,"eighty":62.625798,"marketCap":4988925891},{"date":"2020-07-24","current":493.404684,"twenty":-18.275409,"median":-3.843641,"eighty":64.1913,"marketCap":4702942991},{"date":"2020-07-31","current":459.87751,"twenty":-18.275409,"median":-3.801907,"eighty":65.132645,"marketCap":4383374911},{"date":"2020-08-07","current":-168.551432,"twenty":-18.529695,"median":-3.789176,"eighty":65.318147,"marketCap":4115199234},{"date":"2020-08-14","current":-176.00909,"twenty":-18.968112,"median":-3.789176,"eighty":65.318147,"marketCap":4297278644},{"date":"2020-08-21","current":-178.020143,"twenty":-19.299259,"median":-3.789176,"eighty":65.318147,"marketCap":4346378709},{"date":"2020-08-28","current":-175.841502,"twenty":-19.749926,"median":-3.789176,"eighty":65.318147,"marketCap":4293186971},{"date":"2020-09-04","current":-150.99661,"twenty":-20.156605,"median":-3.789176,"eighty":65.318147,"marketCap":3686596580},{"date":"2020-09-11","current":-139.139773,"twenty":-20.285462,"median":-3.789176,"eighty":65.318147,"marketCap":3397110777},{"date":"2020-09-18","current":-180.575857,"twenty":-20.45098,"median":-3.789176,"eighty":65.318147,"marketCap":4408776709},{"date":"2020-09-25","current":-188.180154,"twenty":-20.855341,"median":-3.789176,"eighty":65.318147,"marketCap":4594436331},{"date":"2020-10-02","current":-183.592438,"twenty":-21.000912,"median":-3.789176,"eighty":65.318147,"marketCap":4482426807},{"date":"2020-10-09","current":-192.935458,"twenty":-21.181622,"median":-3.789176,"eighty":65.318147,"marketCap":4710537528},{"date":"2020-10-16","current":-206.887142,"twenty":-21.519563,"median":-3.789176,"eighty":65.318147,"marketCap":5051169232},{"date":"2020-10-23","current":-246.689245,"twenty":-21.724568,"median":-3.789176,"eighty":65.318147,"marketCap":6022941360},{"date":"2020-10-30","current":-240.069527,"twenty":-21.896478,"median":-3.789176,"eighty":65.318147,"marketCap":5861320311},{"date":"2020-11-06","current":-278.405237,"twenty":-22.1947,"median":-3.789176,"eighty":65.318147,"marketCap":6797290309},{"date":"2020-11-13","current":-287.1617,"twenty":-22.423055,"median":-3.789176,"eighty":65.318147,"marketCap":7011080177},{"date":"2020-11-20","current":-288.25102,"twenty":-22.812061,"median":-3.789176,"eighty":65.318147,"marketCap":7037676046},{"date":"2020-11-27","current":-76.551382,"twenty":-23.016886,"median":-3.789176,"eighty":65.318147,"marketCap":6472649005},{"date":"2020-12-04","current":-79.346559,"twenty":-23.27504,"median":-3.789176,"eighty":65.318147,"marketCap":6708989578},{"date":"2020-12-11","current":-90.004689,"twenty":-23.443255,"median":-3.789176,"eighty":65.318147,"marketCap":7610166460},{"date":"2020-12-18","current":-97.417984,"twenty":-23.662829,"median":-3.789176,"eighty":65.318147,"marketCap":8236982763},{"date":"2020-12-24","current":-102.315619,"twenty":-23.828206,"median":-3.789176,"eighty":65.318147,"marketCap":8651092550},{"date":"2020-12-31","current":-93.249524,"twenty":-23.877135,"median":-3.789176,"eighty":65.318147,"marketCap":7884527038},{"date":"2021-01-08","current":-97.077701,"twenty":-23.97186,"median":-3.789176,"eighty":65.318147,"marketCap":8208210867},{"date":"2021-01-15","current":-98.122854,"twenty":-24.454235,"median":-3.789176,"eighty":65.318147,"marketCap":8296581690},{"date":"2021-01-22","current":-99.739195,"twenty":-24.744147,"median":-3.789176,"eighty":65.318147,"marketCap":8433248195},{"date":"2021-01-29","current":-94.726725,"twenty":-24.828261,"median":-3.789176,"eighty":65.318147,"marketCap":8009428769},{"date":"2021-02-05","current":-91.510733,"twenty":-25.440997,"median":-3.789176,"eighty":65.318147,"marketCap":9390099332},{"date":"2021-02-12","current":-89.21462,"twenty":-26.042831,"median":-3.805477,"eighty":65.318147,"marketCap":9154490562},{"date":"2021-02-19","current":-90.53969,"twenty":-26.322299,"median":-3.843641,"eighty":65.318147,"marketCap":9290458619},{"date":"2021-02-26","current":-80.576379,"twenty":-26.916244,"median":-3.873833,"eighty":65.318147,"marketCap":8268103380},{"date":"2021-03-05","current":-69.79375,"twenty":-28.366158,"median":-3.907377,"eighty":65.320437,"marketCap":7161676290},{"date":"2021-03-12","current":-73.576774,"twenty":-29.531319,"median":-3.935488,"eighty":65.320437,"marketCap":7549859903},{"date":"2021-03-19","current":-68.175344,"twenty":-30.12048,"median":-3.970626,"eighty":65.320437,"marketCap":6995608434},{"date":"2021-03-26","current":-63.674153,"twenty":-30.547075,"median":-3.999327,"eighty":65.318147,"marketCap":6533732209},{"date":"2021-04-01","current":-67.841548,"twenty":-30.954671,"median":-4.016306,"eighty":65.318147,"marketCap":6961356938},{"date":"2021-04-09","current":-62.86495,"twenty":-31.342858,"median":-4.012792,"eighty":65.320437,"marketCap":6450698281},{"date":"2021-04-16","current":-68.42822,"twenty":-31.889554,"median":-4.012792,"eighty":65.320437,"marketCap":7021556536},{"date":"2021-04-23","current":-72.413545,"twenty":-32.415644,"median":-4.012792,"eighty":65.320437,"marketCap":7430498631},{"date":"2021-04-30","current":-73.597004,"twenty":-32.808234,"median":-4.012792,"eighty":65.320437,"marketCap":7551935751},{"date":"2021-05-07","current":-63.043178,"twenty":-45.932572,"median":-4.012792,"eighty":65.320437,"marketCap":6909154068},{"date":"2021-05-14","current":-69.168946,"twenty":-56.438632,"median":-4.033875,"eighty":65.320437,"marketCap":7580501519},{"date":"2021-05-21","current":-70.498571,"twenty":-57.863948,"median":-4.083069,"eighty":65.320437,"marketCap":7726220345},{"date":"2021-05-28","current":-68.950508,"twenty":-58.296058,"median":-4.111179,"eighty":65.320437,"marketCap":7556561997},{"date":"2021-06-04","current":-72.312558,"twenty":-58.476641,"median":-4.111179,"eighty":65.320437,"marketCap":7925022458},{"date":"2021-06-11","current":-84.250683,"twenty":-59.153827,"median":-4.111179,"eighty":65.320437,"marketCap":9233369349},{"date":"2021-06-18","current":-81.335007,"twenty":-59.54079,"median":-4.132262,"eighty":65.320437,"marketCap":8913828780},{"date":"2021-06-25","current":-85.779751,"twenty":-60.082539,"median":-4.188484,"eighty":65.320437,"marketCap":9400946000},{"date":"2021-07-02","current":-59.956551,"twenty":-60.959657,"median":-4.346124,"eighty":65.320437,"marketCap":6570878221},{"date":"2021-07-09","current":-63.764974,"twenty":-61.333721,"median":-4.547082,"eighty":65.320437,"marketCap":6988258574},{"date":"2021-07-16","current":-60.24147,"twenty":-61.430462,"median":-4.684632,"eighty":65.320437,"marketCap":6602103684},{"date":"2021-07-23","current":-64.933144,"twenty":-61.694887,"median":-4.836997,"eighty":65.320437,"marketCap":7116282972},{"date":"2021-07-30","current":-65.806897,"twenty":-62.139895,"median":-5.073506,"eighty":65.320437,"marketCap":7212041058},{"date":"2021-08-06","current":-53.65037,"twenty":-62.324426,"median":-5.25661,"eighty":65.320437,"marketCap":6754957196},{"date":"2021-08-13","current":-50.11453,"twenty":-62.324426,"median":-5.302386,"eighty":65.320437,"marketCap":6309770173},{"date":"2021-08-20","current":-49.625972,"twenty":-62.324426,"median":-5.37105,"eighty":65.320437,"marketCap":6248257212},{"date":"2021-08-27","current":-54.710294,"twenty":-62.324426,"median":-5.386309,"eighty":65.320437,"marketCap":6888409043},{"date":"2021-09-03","current":-55.935832,"twenty":-62.324426,"median":-5.401568,"eighty":65.320437,"marketCap":7042712742},{"date":"2021-09-10","current":-52.987918,"twenty":-62.324426,"median":-5.401568,"eighty":65.320437,"marketCap":6671549791},{"date":"2021-09-17","current":-53.7663,"twenty":-62.324426,"median":-5.500749,"eighty":65.320437,"marketCap":6769553492},{"date":"2021-09-24","current":-54.130649,"twenty":-62.324426,"median":-5.561784,"eighty":65.320437,"marketCap":6815427564},{"date":"2021-10-01","current":-51.836907,"twenty":-62.324426,"median":-9.576545,"eighty":65.320437,"marketCap":6526629425},{"date":"2021-10-08","current":-49.957198,"twenty":-62.324426,"median":-10.599494,"eighty":65.320437,"marketCap":6289960914},{"date":"2021-10-15","current":-54.78482,"twenty":-62.324426,"median":-12.617221,"eighty":65.320437,"marketCap":6897792376},{"date":"2021-10-22","current":-54.677172,"twenty":-62.324426,"median":-13.619752,"eighty":65.320437,"marketCap":6884238673},{"date":"2021-10-29","current":-52.847147,"twenty":-62.324426,"median":-14.182147,"eighty":65.320437,"marketCap":6653825717},{"date":"2021-11-05","current":-66.849736,"twenty":-62.691778,"median":-14.893608,"eighty":65.320437,"marketCap":8416849736},{"date":"2021-11-12","current":-61.227171,"twenty":-62.849328,"median":-15.49945,"eighty":65.320437,"marketCap":7708929388},{"date":"2021-11-19","current":-58.883745,"twenty":-62.849328,"median":-15.600362,"eighty":65.320437,"marketCap":7413875694},{"date":"2021-11-26","current":-53.447273,"twenty":-62.849328,"median":-15.768963,"eighty":65.320437,"marketCap":7527941490},{"date":"2021-12-03","current":-50.092904,"twenty":-62.849328,"median":-16.040498,"eighty":65.320437,"marketCap":7055485290},{"date":"2021-12-10","current":-52.000145,"twenty":-62.849328,"median":-16.358374,"eighty":65.320437,"marketCap":7324116359},{"date":"2021-12-17","current":-51.695877,"twenty":-62.849328,"median":-16.725153,"eighty":65.320437,"marketCap":7281260819},{"date":"2021-12-23","current":-52.133726,"twenty":-62.849328,"median":-16.774057,"eighty":65.320437,"marketCap":7342930987},{"date":"2021-12-31","current":-49.202363,"twenty":-62.849328,"median":-17.043029,"eighty":65.320437,"marketCap":6930054440},{"date":"2022-01-07","current":-43.747802,"twenty":-62.849328,"median":-17.532069,"eighty":65.318147,"marketCap":6161790486},{"date":"2022-01-14","current":-42.901789,"twenty":-62.849328,"median":-17.703232,"eighty":65.318147,"marketCap":6042631179},{"date":"2022-01-21","current":-37.729233,"twenty":-62.849328,"median":-17.9233,"eighty":65.318147,"marketCap":5314086994},{"date":"2022-01-28","current":-37.50079,"twenty":-62.849328,"median":-18.094464,"eighty":65.318147,"marketCap":5281911207},{"date":"2022-02-04","current":-28.67194,"twenty":-62.849328,"median":-18.47347,"eighty":65.318147,"marketCap":5246620871},{"date":"2022-02-11","current":-29.190628,"twenty":-62.849328,"median":-18.89431,"eighty":65.318147,"marketCap":5341534615},{"date":"2022-02-18","current":-25.502177,"twenty":-62.849328,"median":-19.299259,"eighty":65.318147,"marketCap":4666592433},{"date":"2022-02-25","current":-25.352334,"twenty":-62.849328,"median":-19.511471,"eighty":65.318147,"marketCap":4639172906},{"date":"2022-03-04","current":-24.735671,"twenty":-62.849328,"median":-19.873469,"eighty":65.318147,"marketCap":4526331010},{"date":"2022-03-11","current":-24.078666,"twenty":-62.849328,"median":-20.265536,"eighty":65.318147,"marketCap":4406106934},{"date":"2022-03-18","current":-27.30606,"twenty":-62.849328,"median":-20.427007,"eighty":65.318147,"marketCap":4996681344},{"date":"2022-03-25","current":-25.421493,"twenty":-62.849328,"median":-20.792261,"eighty":65.318147,"marketCap":4651828072},{"date":"2022-04-01","current":-28.354963,"twenty":-62.849328,"median":-20.994442,"eighty":65.318147,"marketCap":5188618027},{"date":"2022-04-08","current":-27.807459,"twenty":-62.849328,"median":-21.14622,"eighty":65.318147,"marketCap":5088431297},{"date":"2022-04-14","current":-27.012137,"twenty":-62.849328,"median":-21.291767,"eighty":65.318147,"marketCap":4942896888},{"date":"2022-04-22","current":-24.585828,"twenty":-62.849328,"median":-21.677169,"eighty":65.318147,"marketCap":4498911484},{"date":"2022-04-29","current":-23.692531,"twenty":-62.849328,"median":-21.85137,"eighty":65.318147,"marketCap":4335448924},{"date":"2022-05-06","current":-21.277749,"twenty":-62.849328,"median":-22.070043,"eighty":65.318147,"marketCap":3893572714},{"date":"2022-05-13","current":-29.922841,"twenty":-62.849328,"median":-22.230837,"eighty":65.318147,"marketCap":3345493368},{"date":"2022-05-20","current":-34.24482,"twenty":-62.849328,"median":-22.60735,"eighty":65.318147,"marketCap":3828707802},{"date":"2022-05-27","current":-32.343906,"twenty":-62.849328,"median":-22.835097,"eighty":65.318147,"marketCap":3616178040},{"date":"2022-06-03","current":-32.968086,"twenty":-62.849328,"median":-23.022811,"eighty":65.318147,"marketCap":3685963932},{"date":"2022-06-10","current":-28.863626,"twenty":-62.849328,"median":-23.265009,"eighty":65.318147,"marketCap":3227068824},{"date":"2022-06-17","current":-27.539606,"twenty":-62.849328,"median":-23.436785,"eighty":65.318147,"marketCap":3079038144},{"date":"2022-06-24","current":-32.589795,"twenty":-62.849328,"median":-23.562992,"eighty":65.320437,"marketCap":3643669452},{"date":"2022-07-01","current":-34.008387,"twenty":-62.849328,"median":-23.735995,"eighty":65.320437,"marketCap":3802273752},{"date":"2022-07-08","current":-39.465239,"twenty":-62.849328,"median":-23.824971,"eighty":65.320437,"marketCap":4412371626},{"date":"2022-07-15","current":-40.477169,"twenty":-62.849328,"median":-23.891697,"eighty":65.320437,"marketCap":4525509360},{"date":"2022-07-22","current":-40.354224,"twenty":-62.849328,"median":-23.943598,"eighty":65.320437,"marketCap":4511763654},{"date":"2022-07-29","current":-40.221822,"twenty":-62.849328,"median":-24.254281,"eighty":65.320437,"marketCap":4496960586},{"date":"2022-08-05","current":-31.604916,"twenty":-62.849328,"median":-24.559153,"eighty":65.320437,"marketCap":4864818339},{"date":"2022-08-12","current":-32.519506,"twenty":-62.849328,"median":-24.631934,"eighty":65.320437,"marketCap":5005597460},{"date":"2022-08-19","current":-29.301251,"twenty":-62.849328,"median":-24.78754,"eighty":65.320437,"marketCap":4510224313},{"date":"2022-08-26","current":-27.547714,"twenty":-62.849328,"median":-24.830151,"eighty":65.320437,"marketCap":4240309457},{"date":"2022-09-02","current":-27.107611,"twenty":-62.849328,"median":-25.139096,"eighty":65.320437,"marketCap":4172566121},{"date":"2022-09-09","current":-26.523099,"twenty":-62.849328,"median":-25.306228,"eighty":65.320437,"marketCap":4082594502},{"date":"2022-09-16","current":-23.786207,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3661315630},{"date":"2022-09-23","current":-21.269366,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3273908425},{"date":"2022-09-30","current":-22.727208,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3498308227},{"date":"2022-10-07","current":-21.743852,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3346944210},{"date":"2022-10-14","current":-22.018917,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3389283795},{"date":"2022-10-21","current":-22.961013,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3534296874},{"date":"2022-10-28","current":-24.666413,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3796802302},{"date":"2022-11-04","current":-23.35298,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3594630783},{"date":"2022-11-11","current":-23.71744,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3650730733},{"date":"2022-11-18","current":-21.124957,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3251680143},{"date":"2022-11-25","current":-20.28601,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3122544408},{"date":"2022-12-02","current":-20.428904,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3596774147},{"date":"2022-12-09","current":-18.207193,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3205613033},{"date":"2022-12-16","current":-19.12839,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3367801787},{"date":"2022-12-23","current":-23.060036,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":4060019152},{"date":"2022-12-30","current":-24.420759,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":4299592084},{"date":"2023-01-06","current":-22.506114,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3962493888},{"date":"2023-01-13","current":-22.168943,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3903130684},{"date":"2023-01-20","current":-20.326549,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3578753174},{"date":"2023-01-27","current":-20.236235,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3562852316},{"date":"2023-02-03","current":-22.267052,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3920403974},{"date":"2023-02-10","current":-23.21593,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3587232598},{"date":"2023-02-17","current":-23.657537,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3655468001},{"date":"2023-02-24","current":-22.872457,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3534160618},{"date":"2023-03-03","current":-22.676187,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3503833773},{"date":"2023-03-10","current":-18.442364,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":2849640388},{"date":"2023-03-17","current":-17.033427,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":2631936960},{"date":"2023-03-24","current":-17.026417,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":2630853859},{"date":"2023-03-31","current":-17.804487,"twenty":-62.849328,"median":-25.329281,"eighty":65.318147,"marketCap":2751078140},{"date":"2023-04-06","current":-17.713362,"twenty":-62.849328,"median":-25.329281,"eighty":65.318147,"marketCap":2736997819},{"date":"2023-04-14","current":-21.379404,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3303459971},{"date":"2023-04-21","current":-20.972845,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3240640076},{"date":"2023-04-28","current":-24.505704,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3786523298},{"date":"2023-05-05","current":-28.503078,"twenty":-62.849328,"median":-25.406021,"eighty":65.320437,"marketCap":4281361861},{"date":"2023-05-12","current":-28.524429,"twenty":-62.849328,"median":-25.564592,"eighty":65.322728,"marketCap":4284568873},{"date":"2023-05-19","current":-25.820017,"twenty":-62.849328,"median":-25.767729,"eighty":65.327309,"marketCap":3878347273},{"date":"2023-05-26","current":-23.891344,"twenty":-62.849498,"median":-25.820017,"eighty":65.341771,"marketCap":3588647132},{"date":"2023-06-02","current":-24.6742,"twenty":-62.849668,"median":-25.85766,"eighty":65.356234,"marketCap":3706237596},{"date":"2023-06-09","current":-25.407238,"twenty":-62.849668,"median":-25.915884,"eighty":65.356234,"marketCap":3816345029},{"date":"2023-06-16","current":-25.435706,"twenty":-62.849668,"median":-25.915884,"eighty":65.356234,"marketCap":3820621046},{"date":"2023-06-23","current":-25.300485,"twenty":-62.849839,"median":-25.72783,"eighty":65.370696,"marketCap":3800309966},{"date":"2023-06-30","current":-25.570926,"twenty":-62.850009,"median":-25.674346,"eighty":65.385159,"marketCap":3840932126},{"date":"2023-07-07","current":-24.581681,"twenty":-62.850179,"median":-25.548283,"eighty":65.399621,"marketCap":3692340541},{"date":"2023-07-14","current":-24.546097,"twenty":-62.853133,"median":-25.4286,"eighty":65.437987,"marketCap":3686995520},{"date":"2023-07-21","current":-24.780953,"twenty":-62.853133,"median":-25.333526,"eighty":65.437987,"marketCap":3722272659},{"date":"2023-07-28","current":-25.499758,"twenty":-62.853133,"median":-25.303356,"eighty":65.437987,"marketCap":3830242084},{"date":"2023-08-04","current":-23.001735,"twenty":-62.853133,"median":-25.189784,"eighty":65.437987,"marketCap":3455021606},{"date":"2023-08-11","current":-17.14665,"twenty":-62.853133,"median":-25.145063,"eighty":65.437987,"marketCap":3105378341},{"date":"2023-08-18","current":-17.176244,"twenty":-62.853133,"median":-25.111888,"eighty":65.437987,"marketCap":3110737987},{"date":"2023-08-25","current":-16.596205,"twenty":-62.853133,"median":-25.111888,"eighty":65.437987,"marketCap":3005688944},{"date":"2023-09-01","current":-16.359455,"twenty":-62.853133,"median":-25.111888,"eighty":65.437987,"marketCap":2962811783},{"date":"2023-09-08","current":-17.886495,"twenty":-62.853133,"median":-25.073568,"eighty":65.437987,"marketCap":3239369468},{"date":"2023-09-15","current":-18.075895,"twenty":-62.856087,"median":-25.01581,"eighty":65.476352,"marketCap":3273671196},{"date":"2023-09-22","current":-16.116786,"twenty":-62.856087,"median":-24.951758,"eighty":65.476352,"marketCap":2918862694},{"date":"2023-09-29","current":-15.939223,"twenty":-62.856087,"median":-24.830151,"eighty":65.476352,"marketCap":2886704823},{"date":"2023-10-06","current":-15.122434,"twenty":-62.859042,"median":-24.823525,"eighty":65.514718,"marketCap":2738778620},{"date":"2023-10-13","current":-15.317753,"twenty":-62.859042,"median":-24.823525,"eighty":65.514718,"marketCap":2774152277},{"date":"2023-10-20","current":-15.004059,"twenty":-62.861996,"median":-24.825913,"eighty":65.553083,"marketCap":2717340040},{"date":"2023-10-23","current":-15.057327,"twenty":-62.861996,"median":-24.825913,"eighty":65.553083,"marketCap":2726987401},{"date":"2023-11-03","current":-15.483478,"twenty":-62.913621,"median":-24.830151,"eighty":65.661983,"marketCap":2804166290},{"date":"2023-11-10","current":-15.826766,"twenty":-62.913621,"median":-24.825913,"eighty":65.661983,"marketCap":2866338172},{"date":"2023-11-17","current":-15.424291,"twenty":-62.913621,"median":-24.825913,"eighty":65.661983,"marketCap":2793447000},{"date":"2023-11-24","current":-17.235431,"twenty":-62.913621,"median":-24.825913,"eighty":65.661983,"marketCap":3121457277},{"date":"2023-12-01","current":-11.082764,"twenty":-62.913621,"median":-24.825913,"eighty":65.661983,"marketCap":2275014400},{"date":"2023-12-08","current":-12.837959,"twenty":-62.897398,"median":-24.823525,"eighty":65.638472,"marketCap":2635312111},{"date":"2023-12-15","current":-14.941857,"twenty":-62.897398,"median":-24.799067,"eighty":65.638472,"marketCap":3067189595},{"date":"2023-12-22","current":-15.051762,"twenty":-62.897398,"median":-24.799067,"eighty":65.638472,"marketCap":3089750359},{"date":"2023-12-29","current":-16.224082,"twenty":-62.913621,"median":-24.810593,"eighty":65.661983,"marketCap":3330398510},{"date":"2024-01-05","current":-20.727623,"twenty":-62.929845,"median":-24.815865,"eighty":65.685495,"marketCap":4254862911},{"date":"2024-01-12","current":-22.510451,"twenty":-62.929845,"median":-24.780146,"eighty":65.685495,"marketCap":4620832875},{"date":"2024-01-19","current":-19.905242,"twenty":-62.946069,"median":-24.739411,"eighty":65.709006,"marketCap":4086048483},{"date":"2024-01-26","current":-20.061314,"twenty":-62.929845,"median":-24.737541,"eighty":65.685495,"marketCap":4118086258},{"date":"2024-02-02","current":-19.419562,"twenty":-62.929845,"median":-24.715611,"eighty":65.685495,"marketCap":3986350531},{"date":"2024-02-09","current":-12.877492,"twenty":-62.929845,"median":-24.670306,"eighty":65.685495,"marketCap":3822219796},{"date":"2024-02-16","current":-12.343191,"twenty":-62.929845,"median":-24.583754,"eighty":65.685495,"marketCap":3663631746},{"date":"2024-02-23","current":-12.606167,"twenty":-62.929845,"median":-24.5259,"eighty":65.685495,"marketCap":3741686802},{"date":"2024-03-01","current":-13.39927,"twenty":-62.849839,"median":-24.403759,"eighty":65.661983,"marketCap":3977090939},{"date":"2024-03-08","current":-13.858435,"twenty":-62.78865,"median":-24.183136,"eighty":65.661983,"marketCap":4113377544},{"date":"2024-03-15","current":-11.445732,"twenty":-62.78865,"median":-24.078666,"eighty":65.661983,"marketCap":3397253381},{"date":"2024-03-22","current":-11.783844,"twenty":-62.78865,"median":-23.934586,"eighty":65.661983,"marketCap":3497609882},{"date":"2024-03-28","current":-11.980033,"twenty":-62.78865,"median":-23.867826,"eighty":65.661983,"marketCap":3555841431},{"date":"2024-04-05","current":-10.898908,"twenty":-62.771965,"median":-23.697907,"eighty":65.685495,"marketCap":3234948424},{"date":"2024-04-12","current":-10.719416,"twenty":-62.450545,"median":-23.597561,"eighty":65.685495,"marketCap":3181672751},{"date":"2024-04-19","current":-9.437928,"twenty":-62.450545,"median":-23.514443,"eighty":65.685495,"marketCap":2801309225},{"date":"2024-04-26","current":-9.129035,"twenty":-62.427752,"median":-23.37361,"eighty":65.661983,"marketCap":2709625509},{"date":"2024-05-03","current":-10.072411,"twenty":-62.427752,"median":-23.21593,"eighty":65.661983,"marketCap":2989632534},{"date":"2024-05-10","current":-6.482305,"twenty":-62.427752,"median":-23.186475,"eighty":65.370696,"marketCap":3068567760},{"date":"2024-05-17","current":-6.595323,"twenty":-62.427752,"median":-23.186475,"eighty":64.679241,"marketCap":3105005750},{"date":"2024-05-24","current":-6.508265,"twenty":-62.427752,"median":-23.186475,"eighty":63.492771,"marketCap":3064019674},{"date":"2024-05-31","current":-6.009659,"twenty":-62.427752,"median":-23.186475,"eighty":62.516156,"marketCap":2829281239},{"date":"2024-06-07","current":-6.513541,"twenty":-62.427752,"median":-23.186475,"eighty":61.77678,"marketCap":3066503678},{"date":"2024-06-14","current":-6.991043,"twenty":-62.450545,"median":-23.188804,"eighty":61.001953,"marketCap":3291306095},{"date":"2024-06-21","current":-6.27611,"twenty":-62.473339,"median":-23.191133,"eighty":60.436538,"marketCap":2954723471},{"date":"2024-06-28","current":-6.777354,"twenty":-62.570212,"median":-23.208812,"eighty":59.933947,"marketCap":3190703908},{"date":"2024-07-05","current":-6.61379,"twenty":-62.570212,"median":-23.208812,"eighty":58.878506,"marketCap":3113699766},{"date":"2024-07-12","current":-7.452716,"twenty":-62.570212,"median":-23.208812,"eighty":57.044321,"marketCap":3508656497},{"date":"2024-07-15","current":-7.415782,"twenty":-62.570212,"median":-23.208812,"eighty":56.809508,"marketCap":3491268465},{"date":"2024-08-02","current":-7.244303,"twenty":-62.781052,"median":-23.464332,"eighty":50.761782,"marketCap":3410538315},{"date":"2024-08-09","current":-5.966088,"twenty":-62.781052,"median":-23.464332,"eighty":47.94868,"marketCap":3213549832},{"date":"2024-08-16","current":-5.229847,"twenty":-62.781052,"median":-23.464332,"eighty":-5.237233,"marketCap":2816984108},{"date":"2024-08-23","current":-5.624509,"twenty":-62.781052,"median":-23.464332,"eighty":-5.400175,"marketCap":3029563227},{"date":"2024-08-30","current":-5.557578,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2993511797},{"date":"2024-09-06","current":-5.366017,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2890330120},{"date":"2024-09-13","current":-4.670166,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2515519569},{"date":"2024-09-20","current":-4.879037,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2628024892},{"date":"2024-09-27","current":-4.528226,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2439065675},{"date":"2024-10-04","current":-4.350513,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2343342914},{"date":"2024-10-11","current":-4.085097,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2200380349},{"date":"2024-10-18","current":-4.809798,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2590730310},{"date":"2024-10-25","current":-4.599773,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2477603410},{"date":"2024-10-31","current":-4.548998,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2450254050},{"date":"2024-11-08","current":-4.936736,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":2659103710},{"date":"2024-11-15","current":-4.941352,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":2661590016},{"date":"2024-11-22","current":-4.218959,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":2272483208},{"date":"2024-11-29","current":-5.402946,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":3239028525},{"date":"2024-12-06","current":-4.628725,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":2774888056},{"date":"2024-12-13","current":-4.595514,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":2754978545},{"date":"2024-12-20","current":-4.04754,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":2426471619},{"date":"2024-12-27","current":-4.053767,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":2430204652},{"date":"2025-01-03","current":-4.078674,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":2445136785},{"date":"2025-01-10","current":-4.099431,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":2457580229},{"date":"2025-01-17","current":-3.947908,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":2366743086},{"date":"2025-01-24","current":-4.468899,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":2679073536},{"date":"2025-01-31","current":-4.199063,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":2517308761},{"date":"2025-02-07","current":-4.27277,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":2561495982},{"date":"2025-02-14","current":-3.766894,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":2409734901},{"date":"2025-02-21","current":-4.131559,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":2643016406},{"date":"2025-02-28","current":-3.733384,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":2388298222},{"date":"2025-03-07","current":-3.483047,"twenty":-62.792449,"median":-23.478536,"eighty":-5.739251,"marketCap":2228153621},{"date":"2025-03-14","current":-2.970544,"twenty":-62.792449,"median":-23.478536,"eighty":-5.739251,"marketCap":1900298532},{"date":"2025-03-21","current":-2.978429,"twenty":-62.792449,"median":-23.478536,"eighty":-5.739251,"marketCap":1905342457},{"date":"2025-03-28","current":-2.720206,"twenty":-62.792449,"median":-23.478536,"eighty":-5.739251,"marketCap":1740153931},{"date":"2025-04-04","current":-2.377224,"twenty":-62.792449,"median":-23.478536,"eighty":-5.739251,"marketCap":1520743218},{"date":"2025-04-11","current":-2.189963,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":1400950013},{"date":"2025-04-17","current":-2.237271,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":1431213559},{"date":"2025-04-25","current":-2.629533,"twenty":-62.792449,"median":-23.478536,"eighty":-5.739251,"marketCap":1682148800},{"date":"2025-05-02","current":-2.767514,"twenty":-62.792449,"median":-23.478536,"eighty":-5.739251,"marketCap":1770417478},{"date":"2025-05-09","current":-2.611792,"twenty":-62.792449,"median":-23.478536,"eighty":-5.739251,"marketCap":1670799970},{"date":"2025-05-16","current":-14.7147,"twenty":-62.792449,"median":-23.478536,"eighty":-5.974802,"marketCap":2118460672},{"date":"2025-05-23","current":-14.762662,"twenty":-62.792449,"median":-23.478536,"eighty":-6.230734,"marketCap":2125365694},{"date":"2025-05-30","current":-16.134371,"twenty":-62.792449,"median":-23.478536,"eighty":-6.469305,"marketCap":2322849316},{"date":"2025-06-06","current":-15.789046,"twenty":-62.792449,"median":-23.478536,"eighty":-6.537285,"marketCap":2273133160},{"date":"2025-06-13","current":-15.558829,"twenty":-62.792449,"median":-23.478536,"eighty":-6.601655,"marketCap":2239989055}],"updateTime":1750017129691}}}